Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation to Host “World Without Parkinson’s” Symposium on Thursday, June 1 to Mark 60th Anniversary

Scientific Progress in Next 20 Years Due to Outpace the Last 200

New York, NY and Miami, FL — The Parkinson’s Foundation is hosting a cutting-edge scientific symposium, World Without Parkinson’s: A Look Into the Future, tomorrow, June 1, in New York City.  The forward-looking event marks the 200th anniversary of the publication of, “An Essay on the Shaking Palsy,” by James Parkinson and the 60th anniversary of the Parkinson’s Foundation.

“Parkinson’s Foundation investments have played a part in many of the major scientific advances of the past 60 years, improving lives worldwide.  Yet there are 10 million people living with Parkinson’s disease who urgently need better treatments and care,” said John L. Lehr, chief executive officer, Parkinson’s Foundation. “We mark our anniversary by reflecting on key successes and recommitting ourselves to creating a world without Parkinson’s disease.”

The symposium, geared for the scientific community, is chaired by Patrik Brundin, M.D., Ph.D., Director of the Center for Neurodegenerative Science and the inaugural holder of the Jay Van Andel Endowed Chair in Parkinson’s Research at the Van Andel Research Institute.

The program includes talks from leaders in the field, each of whom will answer the question, “How will your area of expertise help to create a world without Parkinson’s?”  Using interactive technology, the program will engage its scientific audience in finding answers.  It also features an intimate interview with world-renowned Parkinsonologist Stanley Fahn, M.D., of Columbia University Medical Center, Parkinson’s Foundation Center of Excellence.

“In 1817, James Parkinson transformed the field by putting Parkinson’s disease on the map,” said James Beck, Ph.D., chief scientific officer, Parkinson’s Foundation.  “Two hundred years later, the Parkinson’s Foundation is ready to transform the field again.  In fact, we predict scientific advances of the next 20 years will outpace those of the last 200.  At this symposium, we bring together innovators in research, technology and healthcare to make it happen.”

Tonight at its 60th anniversary gala, the Parkinson’s Foundation will present its most prestigious scientific honor, the James Parkinson Award, to Heiko Braak, M.D., of the Center for Biomedical Research, University of Ulm, Germany. The award recognizes his contribution in focusing the field on the spread of alpha-synuclein A protein in the human brain that is associated with the development of Parkinson’s. It is the main component of Lewy bodies. as a major factor in the progression of Parkinson’s.

“Never before in history have we known more about Parkinson’s than we do now.  This symposium is a starting point for the next two decades, during which I believe we can change the course of Parkinson’s as we know it today,” said Dr. Brundin.  “I applaud the Parkinson’s Foundation for bringing together innovators to improve care, diagnosis and treatment.”

Thanks to our corporate sponsors: Lundbeck LLC (Gold); Adamas (Silver); AbbVie, Inc. (Bronze); Sunovion (Bronze); Nature Publishing Group (Media Partner) and Concise (Technology Sponsor).

World Without Parkinson’s Faculty


Patrik Brundin, M.D., Ph.D., Van Andel Research Institute, Chair
Ray Dorsey, M.D., University of Rochester Medical Center
Michael S. Okun, M.D., University of Florida College of Medicine, Parkinson’s Foundation Center of Excellence
Beth-Anne Sieber, Ph.D., National Institutes of Health (federal liaison)


Bastiaan R. Bloem, M.D., Ph.D., Radboud University Nijmegen Medical Centre, Netherlands, Parkinson’s Foundation Center of Excellence
Dennis Boyle, M.S., IDEO
Elizabeth M. Bradshaw, Ph.D., Brigham and Women’s Hospital
Helen Bronte-Stewart, M.D., M.S.E., Stanford University
Alice Chen-Plotkin, M.D., Perelman School of Medicine, University of Pennsylvania, Parkinson’s Foundation Center of Excellence
James Dahlman, Ph.D., Georgia Institute of Technology
Stanley Fahn, M.D., Columbia University Medical Center, Parkinson’s Foundation Center of Excellence
James Giordano, Ph.D., Georgetown University, Parkinson’s Foundation Center of Excellence
Dave Iverson, film producer and founding member, Patient Council, Michael J. Fox Foundation for Parkinson’s Research
Max A. Little, Ph.D., Massachusetts Institute of Technology and Aston University
Haydeh Payami, Ph.D., University of Alabama at Birmingham School of Medicine; Center for Neurodegeneration and Experimental Therapeutics
David Vaillancourt, Ph.D., University of Florida College of Medicine, Parkinson’s Foundation Center of Excellence
Laura A. Volpicelli-Daley, Ph.D., University of Alabama at Birmingham School of Medicine; Center for Neurodegeneration and Experimental Therapeutics

About the Parkinson’s Foundation
The Parkinson’s Foundation is working toward a world without Parkinson’s disease.  Formed by the merger of National Parkinson Foundation and the Parkinson’s Disease Foundation, the mission of the Parkinson’s Foundation is to invest in promising scientific research that will end Parkinson’s disease and improve the lives of people with Parkinson’s, and their families, through improved treatments, support and the best care.  For more information, visit or call (800) 4PD-INFO (473-4636).

About Parkinson's Disease
Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the US and over 10 million worldwide.  Parkinson’s is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the US.  It is associated with a loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety A feeling of nervousness, worried thoughts and physical distress.).  Although promising research is being conducted, there is currently no cure for Parkinson's disease.

Wednesday, May 31, 2017
New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Delegates From The Parkinson’s Community Converge On Capitol Hill To Advocate For Critical Research Funding
Monday, March 5, 2018

—2018 Parkinson’s Policy Forum Co-Sponsored by the Parkinson’s Foundation and the Michael J. Fox Foundation for Parkinson’s Research—


mail icon

Subscribe to get the latest news on treatments, research and other updates.